Lexicon Pharmaceuticals (LXRX)

• Market cap: $708M
• 1 day: -1.18%
• 5 days: -2.91%
• 1 month: 26.52%
• 3 months: 39.17%
• 6 months: 51.82%
• Year to date: 46.49%
• 1 year: 334.56%
• 5 years: -74.92%
• 10 years: -85.01%
• Sector: Healthcare
• Industry: Biotechnology

About: Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Employees: 81